Kyle Piskel - Chief Financial Officer at Adaptive Biotechnologies Corp

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Issuer Symbol
ADPT on Nasdaq
All Insider Reports
All Insider Reports

Kyle Piskel - trading volume in the past year for Adaptive Biotechnologies Corp

Holdings reported by Kyle Piskel for Adaptive Biotechnologies Corp

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 216,637 $3,999,119 $18.46 04 Feb 2026 Direct
Stock Option (right to buy) 2,146 04 Feb 2026 Direct Common Stock

Transactions reported by Kyle Piskel for Adaptive Biotechnologies Corp

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.